Hydroxy methyl phenyl pyrazolyl urea compounds useful in the treatment of cancer
US8101773B2 · kind B2 · utility
57Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2007 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Dec 20, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compound 4-{4-[({3-tert-Butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}carbamoyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide and alternative forms thereof (e.g., salts, solvates, hydrates, prodrugs, polymorphs and metabolites); pharmaceutical compositions which contain them; and methods for treating cancer using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.